Thomas Struengmann
ACTUAL TIME TOTAL ASSETS– since 4/28/17
$ 3.2 B
In 2005, Thomas Struengmann and also his twin bro, Andreas, who with each other started generic medicine manufacturer Hexal AG in 1986, sold the business (together with their 68% stake in U.S.-based Years Labs) to Novartis for $7.5 billion. Ever since, they have actually been actively investing in biotechnology and pharmaceutical companies. Their holdings additionally consist of a personal financial institution, Stuttgart-based Sudwestbank. In 2008, they developed a neuroscience research center in Frankfurt named after their dad, Ernst Struengmann. After getting a business degree from the College of Augsburg, Thomas worked as manager for the United States pharmaceutical firm Schering-Plough. Like his brother, he is stated to be an achieved golf player and also likes to . He accumulates modern-day art and Swiss watches.
Strungmann and his brother Andreas sold two pharmaceutical companies for 5.7 billion euros ($7.5 billion) in 2005. The pair sold drugmaker Hexal as well as their 68 percent stake in affiliate EON Labs. The siblings, who shared the proceeds equally, invest in startup companies through Zurich-based Santo Holding.
Source:
1. Forbes
2. bloomberg